Featured Research

from universities, journals, and other organizations

Unsolved puzzle in hepatology on the brink of resolution

Date:
February 26, 2013
Source:
Medical University of Vienna
Summary:
Primary sclerosing cholangitis is a currently incurable liver disease that mostly affects younger people aged between 30 and 40. There are now justified hopes that this disease could be cured using synthetically manufactured bile acids, a process under development.

Primary sclerosing cholangitis is a currently incurable liver disease that mostly affects younger people aged between 30 and 40. There are now justified hopes that this disease could be cured using synthetically manufactured bile acids, a process that is being researched in the Clinical Department of Gastroenterology and Hepatology at the MedUni Vienna.

"Primary sclerosing cholangitis is one of the last big 'black boxes' in hepatology, one of the last unsolved mysteries," says Trauner. "If the cure works with Nor-Urso, this would be a remarkable breakthrough in hepatology." It would also underpin the internationally leading position that hepatology at the MedUni Vienna holds.

The first clinical study phase of this synthetically manufactured bile acid (active ingredient nor-ursodeoxycholic acid / Nor-Urso) has been successfully completed, following the extremely promising results from pre-clinical models. These were able to demonstrate that Nor-Urso works directly on the biliary tract and flushes the bile ducts of toxins by increasing bicarbonate-rich biliary secretions. The underlying mechanisms have now been explored further in collaboration with the MedUni Graz. A phase II study was recently launched which is being carried out in a multi-centre version across 30 centres throughout Europe and which is being led by Trauner.

Also effective for fatty liver and diabetes? Bile acids are not only involved in the secretion of bile fluids and fat digestion, but also have hormone-like effects, particularly on the regulation of fat and glucose metabolism in the liver. Researchers at the MedUni Vienna are currently also investigating what role these effects of Nor-Urso and other bile acid derivatives play in the treatment of fatty liver, diabetes, fat metabolism problems and arteriosclerosis and how they could replace current conventional treatment methods and drugs.

Generally speaking, bile acid research is a very traditional domain that has taken a completely new direction in terms of research over the last few years. Research into the therapeutic benefit and mechanisms of bile acids is at the heart of the work carried out by Trauner and his team -- and the MedUni Vienna is again playing a leading role worldwide in this. Trauner and his team are also part of a special research division (SFB 35) at the MedUni Vienna which is primarily dedicated to researching transport processes for bile acids and medicines.

Primary sclerosing cholangitis, the cause of which is not yet known, is one of the rare (orphan) diseases with a poor prognosis since the disease can progress to liver cirrhosis and cancer of the bile ducts. The condition affects 0.01 per cent of the population. "Without a liver transplant, the average life expectancy of an affected patient is twelve years, with 65% living more than a decade," says Trauner. Of note is the fact that there is a marked north/south divide within Europe for this condition. Primary sclerosing cholangitis is much more widespread in Scandinavia, for example, than in more southerly countries.


Story Source:

The above story is based on materials provided by Medical University of Vienna. Note: Materials may be edited for content and length.


Cite This Page:

Medical University of Vienna. "Unsolved puzzle in hepatology on the brink of resolution." ScienceDaily. ScienceDaily, 26 February 2013. <www.sciencedaily.com/releases/2013/02/130226081012.htm>.
Medical University of Vienna. (2013, February 26). Unsolved puzzle in hepatology on the brink of resolution. ScienceDaily. Retrieved September 23, 2014 from www.sciencedaily.com/releases/2013/02/130226081012.htm
Medical University of Vienna. "Unsolved puzzle in hepatology on the brink of resolution." ScienceDaily. www.sciencedaily.com/releases/2013/02/130226081012.htm (accessed September 23, 2014).

Share This



More Health & Medicine News

Tuesday, September 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Ebola Costs Keep Mounting

Ebola Costs Keep Mounting

Reuters - Business Video Online (Sep. 23, 2014) The WHO has warned up to 20,000 people could be infected with Ebola over the next few weeks. As Sonia Legg reports, the implications for the West African countries suffering from the disease are huge. Video provided by Reuters
Powered by NewsLook.com
Ebola Cases Could Reach 1.4 Million Within 4 Months

Ebola Cases Could Reach 1.4 Million Within 4 Months

Newsy (Sep. 23, 2014) Health officials warn that without further intervention, the number of Ebola cases in Liberia and Sierra Leone could reach 1.4 million by January. Video provided by Newsy
Powered by NewsLook.com
WHO: Ebola Cases to Triple in Weeks Without Drastic Action

WHO: Ebola Cases to Triple in Weeks Without Drastic Action

AFP (Sep. 23, 2014) The number of Ebola infections will triple to 20,000 by November, soaring by thousands every week if efforts to stop the outbreak are not stepped up radically, the WHO warned in a study on Tuesday. Duration: 01:01 Video provided by AFP
Powered by NewsLook.com
5 Ways Men Can Prevent Most Heart Attacks

5 Ways Men Can Prevent Most Heart Attacks

Newsy (Sep. 23, 2014) No surprise here: A recent study says men can reduce their risk of heart attack by maintaining a healthy lifestyle, which includes daily exercise. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins